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ABSTRACT 22 
 23 
Recently, two influenza A virus (FLUAV) genomes were identified in Central and South 24 
American bats. These sequences exhibit notable divergence from classical FLUAV 25 
counterparts, and functionally, bat FLUAV glycoproteins lack canonical receptor binding and 26 
destroying activity. Nevertheless, other features that distinguish these viruses from classical 27 
FLUAVs have yet to be explored. Here, we studied the viral non-structural protein, NS1, a 28 
virulence factor that modulates host signaling to promote efficient propagation. Like all 29 
FLUAV NS1 proteins, bat FLUAV NS1s bind double-stranded RNA and act as interferon-30 
antagonists. Unexpectedly, we found that bat FLUAV NS1s are unique in being unable to 31 
bind host p85β, a regulatory subunit of the cellular metabolism-regulating enzyme, 32 
phosphoinositide 3-kinase (PI3K). Furthermore, neither bat FLUAV NS1 alone, nor infection 33 
with a chimeric bat FLUAV, efficiently activates Akt, a PI3K effector. Structure-guided 34 
mutagenesis revealed that the bat FLUAV NS1:p85β interaction can be re-engineered (in a 35 
strain-specific manner) by changing 2-4 NS1 residues (96L, 99M, 100I and 145T) thereby 36 
creating a hydrophobic patch. Notably, ameliorated p85β-binding is insufficient for bat 37 
FLUAV NS1 to activate PI3K, and a chimeric bat FLUAV expressing NS1 with engineered 38 
hydrophobic patch mutations exhibits cell-type dependent, but species independent, 39 
propagation phenotypes. We hypothesize that bat FLUAV hijack of PI3K in the natural bat 40 
host has been selected against, perhaps because genes in this metabolic pathway were 41 
differentially shaped by evolution to suit unique energy-use strategies of this flying mammal. 42 
Our data expand understanding of the enigmatic functional divergence between bat FLUAVs 43 
and classical mammalian and avian FLUAVs.  44 
 45 
 46 
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IMPORTANCE 48 
 49 
The potential for novel influenza A viruses to establish infections in humans from animals is a 50 
source of continuous concern due to possible severe outbreaks or pandemics. The recent 51 
discovery of influenza A-like viruses in bats has raised questions over whether these entities 52 
could be a threat to humans. Understanding unique properties of the newly-described bat 53 
influenza A-like viruses, such as their mechanisms to infect cells or how they manipulate host 54 
functions, is critical to assess their likelihood of causing disease. Here, we characterized the 55 
bat influenza A-like virus NS1 protein, a key virulence factor, and found unexpected 56 
functional divergence of this protein from counterparts in other influenza A viruses. Our study 57 
dissects the molecular changes required by bat influenza A-like virus NS1 to adopt classical 58 
influenza A virus properties, and suggests consequences of bat influenza A-like virus 59 
infection, potential future evolutionary trajectories, and intriguing virus-host biology in bat 60 
species. 61 
  62 
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INTRODUCTION 63 
 64 
In 2012 and 2013, two novel influenza A virus (FLUAV) genomes were discovered by RT-65 
PCR analysis of rectal samples from two species of Guatemalan and Peruvian fruit bats (1, 2). 66 
Due to high sequence and evolutionary divergence in multiple genomic segments, as 67 
compared with other FLUAVs, these viruses were designated the unique subtypes HL17NL10 68 
and HL18NL11 (1-3). Functional characterization of bat FLUAVs and their encoded proteins 69 
using reverse genetic or reductionist techniques have since revealed remarkable properties of 70 
these viruses [reviewed in (3-6)]. For example, bat FLUAV surface glycoproteins lack 71 
canonical receptor binding or destroying features (7-10), and these viruses preferentially enter 72 
polarized cells at the basolateral membrane (11). Thus, bat FLUAVs appear to have evolved 73 
unique mechanisms for entering host cells that are distinct from classical mammalian and 74 
avian FLUAVs. Other features that distinguish bat FLUAVs from other FLUAVs have yet to 75 
be explored in detail. 76 
 77 
The precise host-range and zoonotic potential of bat FLUAVs is unknown, although 78 
depending upon the experimental system used these viruses can infect cells from an array of 79 
species, including bats, humans and dogs (11-13). Reassortment of bat FLUAVs with 80 
classical FLUAVs has never been observed in experimental studies (14-16), although a cell-81 
line derived from the bat species Pteropus alecto can support replication and reassortment of 82 
avian, swine and human FLUAVs (17). In addition, there is evidence that bat species can be 83 
naturally infected with classical FLUAVs: in one study 30% of Ghanaian fruit bats analyzed 84 
were seropositive for avian H9 FLUAVs (18), and the respiratory and gastro-intestinal tracts 85 
of North American little brown bats harbor receptors for both avian and mammalian FLUAVs 86 
(19). Thus, these data suggest that bats could represent an additional reservoir for FLUAVs, 87 
with the potential to provide either new gene segments or entire viruses that cross the species 88 
 o
n
 January 19, 2018 by Universitaet Zuerich
http://jvi.asm.org/
D
ow
nloaded from
 
5 
 
barrier with unknown consequences. Understanding fundamental properties of the newly-89 
described bat FLUAVs, such as their mechanisms to infect cells of certain species and how 90 
they modulate functions of the infected host-cell environment, will be critical to assess their 91 
likelihood for causing disease in particular hosts. 92 
  93 
We have focused on the non-structural protein, NS1, of bat FLUAVs, which shares only 94 
~50% sequence identity with other FLUAV NS1 proteins. NS1 is a multifunctional virulence 95 
factor that can contribute to virus host-range and virulence (20, 21). A major role of NS1 96 
during FLUAV infection is to antagonize the host innate interferon (IFN) system through 97 
multiple mechanisms, some of which appear to be strain-dependent (22-31). We and others 98 
have recently demonstrated that bat FLUAV NS1 proteins, like classical FLUAVs, harbor a 99 
structurally- and functionally- conserved N-terminal double-stranded (ds) RNA-binding 100 
domain that is critical for potent IFN-antagonism in human cells (15, 32, 33). The C-terminal 101 
effector domain (ED) of bat FLUAV NS1 may play a minor role in supporting IFN-102 
antagonism in vitro (15), possibly by promoting NS1 oligomerization (34-37). However, a 103 
striking finding is that deletion of the bat FLUAV NS1 ED has minimal impact on viral 104 
pathogenesis in a mouse model as compared to deletion of this NS1 domain in a human H1N1 105 
FLUAV (15). This suggests unappreciated functional differences between the EDs of bat and 106 
classical FLUAVs that remain to be explored. Here, we investigated one such activity of the 107 
NS1 ED: modulation of the host intracellular metabolic environment by binding the p85β 108 
regulatory subunit of phosphoinositide 3-kinase (PI3K) (38). The NS1 EDs of all classical 109 
human and avian FLUAV strains tested to date bind the inter-SH2 (iSH2) domain of host 110 
p85β to activate PI3K signaling (38-42). This activation generally benefits classical FLUAV 111 
replication, as viruses engineered to express NS1 proteins unable to bind p85β are attenuated 112 
for replication in vitro and for virulence in vivo (38, 43, 44). In this study, we found that bat 113 
FLUAV NS1 proteins uniquely lack the ability to bind host p85β and activate PI3K signaling. 114 
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We map the bat FLUAV NS1 ED residues responsible for this atypical binding phenotype, 115 
and characterize the impact that artificial introduction of this property into a model bat 116 
FLUAV has on virus propagation in vitro. Our data reveal unexpected functional divergence 117 
of bat FLUAV NS1 proteins from classical FLUAV NS1 proteins, and may suggest that 118 
specific metabolic conditions in the bat host in vivo negate any requirement for NS1 to evolve 119 
to engage with host PI3K signaling in these species. 120 
 121 
RESULTS 122 
 123 
Bat FLUAV NS1 proteins are unable to bind p85β. As part of a larger project to 124 
understand the interplay between FLUAV NS1 proteins and host PI3K, we screened a panel 125 
of different NS1s from various virus strains for their ability to interact with human p85β, or 126 
the related isoform, p85α. To this end, 293T cells were co-transfected with plasmids 127 
expressing FLAG-tagged human p85α or p85β, together with plasmids expressing V5-tagged 128 
GST or NS1 proteins from representative human, swine, avian and bat strains. Soluble 129 
fractions were prepared from cell lysates 48 h post-transfection, and were subjected to 130 
immunoprecipitation with an antibody raised against the V5 tag. Western blot analysis of the 131 
resulting precipitates revealed that NS1 proteins from human (PR8, H1N1; and Cal/09, 132 
pdmH1N1), swine (Sw/Tx/98, H3N2) and avian (Nig/07, H5N1; and Sh/13, H7N9) strains 133 
were all capable of interacting specifically with human p85β, but not p85α (Fig. 1A). 134 
Surprisingly, NS1 proteins from bat FLUAVs (Guat/09, HL17NL10; and Peru/10, 135 
HL18NL11) were unable to precipitate either p85α or p85β (Fig. 1B). This phenotype has not 136 
previously been observed for a naturally-occurring FLUAV NS1 protein, but is akin to the 137 
more distantly related influenza B virus (FLUBV) NS1, which is also unable to bind PI3K 138 
subunits (45, 46). 139 
 140 
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Bat FLUAV NS1 proteins do not show a species-specific interaction with p85β.  To 141 
examine if the interaction between bat FLUAV NS1 proteins and host p85β is species-142 
specific, we generated an expression vector for bat (Myotis lucifugus) p85β, and assessed its 143 
co-immunoprecipitation with various NS1 proteins. While PR8/NS1 interacted with this bat 144 
p85β to an extent similar to human p85β, neither the Guat/09 nor Peru/10 bat FLUAV NS1 145 
proteins were able to precipitate bat p85β (Fig 2A). To exclude the possibility that this lack of 146 
p85β-binding was due to M. lucifugus not being the primary bat host species for bat FLUAVs, 147 
we sought to generate expression vectors mimicking p85β from the bat species Sturnia lilium 148 
(in which the HL17NL10 virus genome was first discovered (1)) and Carollia perspicillata 149 
(in which individual animals sero-positive for HL18NL11 have been identified (2)). To this 150 
end, we cloned and sequenced the region encoding the p85β iSH2 domain from tissue 151 
originally derived from S. lilium and C. perspicillata. As shown in Fig 2B, the human and bat 152 
p85β iSH2 domains are almost identical, with only 5 residue positions that differ. Three of 153 
these differences are conserved in the bat species sequenced (E544, T547 and L550; bat 154 
numbering), while two residue positions (605 and 611) differ between the M. lucifugus p85β 155 
iSH2 domain and the two other bat species (Fig. 2B). We therefore substituted these two 156 
residue positions in the M. lucifugus p85β for the respective residues from C. perspicillata 157 
(A605S) or S. lilium (A605S/D611E), and assessed their abilities to co-precipitate with NS1. 158 
However, neither bat p85β variant interacted with the bat FLUAV NS1 proteins, while their 159 
interaction with PR8/NS1 was unaffected (Fig. 2C). These data suggest that the bat FLUAV 160 
NS1 proteins have not specifically evolved to bind bat p85β.   161 
 162 
Bat FLUAV is an inefficient activator of PI3K signaling during infection. In contrast to 163 
PR8/NS1, and consistent with their inability to bind p85β, isolated expression of the V5-164 
tagged NS1 proteins from Guat/09 or Peru/10 failed to stimulate phosphorylation of the 165 
downstream effector of PI3K, Akt (Fig. 3A). To assess further the impact of bat FLUAV 166 
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infection on host PI3K signaling, we generated recombinant, chimeric bat FLUAVs 167 
possessing the six complete internal gene segments of Guat/09 (variant C3; chHL17) and 168 
modified HA and NA glycoprotein gene segments from PR8, where the untranslated regions 169 
were replaced by the genome ends and packaging sequences of the corresponding segments of 170 
Guat/09. Within these viruses, we also re-engineered the NS segment to allow expression of 171 
different V5-tagged NS1 proteins (from PR8, Guat/09 or Peru/10) separated from Guat/09 172 
NEP by a 2A sequence (Fig. 3B). Immunoprecipitations from infected cell lysates revealed 173 
that endogenous p85β could be co-precipitated with V5-PR8/NS1, but not with the V5-tagged 174 
NS1 proteins derived from Guat/09 or Peru/10 (Fig. 3C). In addition, we observed that only 175 
the chimeric bat FLUAV expressing V5-tagged PR8/NS1 efficiently lead to increased 176 
phosphorylation of Akt during infection (Figure 3D). These infection data indicate that 177 
additional bat FLUAV internal gene segment products are unable to compensate bat FLUAV 178 
NS1 for either binding host p85β or activating PI3K. 179 
 180 
A small number of amino acid changes can establish an interaction between bat FLUAV 181 
NS1 and p85β. We analyzed the crystal structure of the PR8/NS1 ED in complex with the 182 
p85β iSH2 domain, taking into account recent mutagenesis data (Fig. 4A) (41, 47). Of the 183 
NS1 residues present at this interface, 6 were selected for substitution analysis in the bat 184 
FLUAV NS1 proteins based on their divergence from residues in NS1 proteins with the 185 
ability to bind p85β (Figs. 4A and 4B). Single amino acid substitutions at these 6 ED residues 186 
in Guat/09 NS1 (Q96L, T99M, I100S, R145T, N163S and S166P; Guat/09 NS1 numbering), 187 
did not result in the establishment of human p85β binding (Fig. 4C). However, combining the 188 
amino acid substitutions Q96L and T99M resulted in partial p85β binding (Fig. 4D). The 189 
interaction between Guat/09 NS1 and human p85β could be enhanced further when the 190 
additional R145T substitution was introduced (Fig. 4D). Substitutions at other positions 191 
(particularly I100S) proved to be disruptive to the interaction (Fig. 4D). From these data, we 192 
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infer that creation of a hydrophobic patch around positions 96, 99 and 100 in the Guat/09 NS1 193 
ED is essential for determining the interaction with p85β. Largely similar, but distinct, results 194 
were obtained for substitution analysis of the Peru/10 NS1 protein: single amino acid 195 
substitution of V96L, T99M or R145T, as well as double substitution of V96L and T99M, did 196 
not establish an interaction with human p85β (Figs. 5A and 5B). In fact, only when N100I 197 
was combined with double substitution of V96L and T99M could some weak p85β binding be 198 
observed, which was strongly enhanced by R145T (Fig. 5B). Notably, mutant Guat/09 and 199 
Peru/10 NS1 constructs generated to possess optimal p85β binding also exhibited the ability 200 
to interact with bat p85β (Fig. 5C). 201 
 202 
A chimeric bat FLUAV expressing an engineered p85β-binding NS1 protein exhibits 203 
cell-type dependent, but species-independent, propagation phenotypes. Using reverse 204 
genetics, we generated chimeric bat FLUAVs as before (chHL17), but possessing authentic 205 
Guat/09 NS segments expressing either wild-type NS1 (WT) or NS1-Q96L/T99M (2x), which 206 
possesses p85β-binding ability with a minimal number of substitutions. Strikingly, we 207 
observed that chHL17-2x exhibited an altered plaque phenotype and markedly enhanced 208 
propagation capability (>100-fold higher peak titers) in canine MDCK cells (Figs. 6A and 209 
6B). Enhanced propagation of the chHL17-2x virus was also observed, to a lesser extent, in 210 
human HAP-1 cells (Fig. 6C). However, such a phenotype was not found in other cell-types: 211 
the chHL17-2x virus exhibited slower replication kinetics in human A549 cells, and a subtle 212 
attenuation in bat EidNi/41 cells (Figs. 6D and 6E). These data indicate that the Q96L/T99M 213 
substitutions in NS1 impact tissue-culture replication of the chimeric bat FLUAV in a cell-214 
type dependent, but species-independent, manner. 215 
 216 
Role of p85β and PI3K activation in the phenotype of a chimeric bat FLUAV expressing 217 
NS1-Q96L/T99M. We hypothesized that the engineered binding of Guat/09 NS1-218 
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Q96L/T99M to p85β, and potential activation of PI3K signaling, was responsible for 219 
modulating propagation of the chHL17-2x virus. However, similar to expression of the wild-220 
type V5-tagged NS1 protein from Guat/09, expression of V5-Guat/09 NS1-Q96L/T99M 221 
failed to stimulate Akt phosphorylation (Fig. 7A), an observation supporting previous data 222 
that other NS1 determinants beyond efficient p85β binding can critically impact PI3K 223 
activation (41, 43, 48). In addition, we assessed propagation of the chHL17-2x virus in human 224 
HAP-1 cells that had been genetically-engineered to lack p85β expression (Fig. 7B). Notably, 225 
the chHL17-2x virus also exhibited slightly enhanced propagation in this p85β knock-out 226 
HAP-1 cell-line (Fig. 7C), which was similar to the enhancement previously observed in 227 
wild-type HAP-1 cells (Figs. 6C and 7D). Overall, these data suggest that, while the 228 
Q96L/T99M substitutions in Guat/09 NS1 permit host p85β-binding, they are not sufficient 229 
for this NS1 to activate host PI3K signaling. Furthermore, these NS1 substitutions may 230 
impact propagation of the chimeric bat FLUAV, at least in some host substrates, in a 231 
p85β/PI3K-independent manner. 232 
 233 
DISCUSSION 234 
 235 
Functional characterization of proteins encoded by the novel bat FLUAV sequences has so far 236 
revealed some remarkable properties, most notably that the HA-like protein does not bind 237 
canonical FLUAV sialic acid receptors, and the NA-like protein lacks neuraminidase activity 238 
(7-10). Herein, we describe an additional feature of classical mammalian and avian FLUAVs 239 
that is missing in their bat-derived counterparts: the multifunctional bat FLUAV NS1 240 
virulence factor is unable to bind host p85β or activate PI3K signaling. This property seems 241 
important for the efficient replication of many classical FLUAV strains in tissue-culture and 242 
in vivo (38, 43, 44, 47). Using a structure-guided approach, we found that p85β-binding could 243 
be engineered into the bat FLUAV NS1 proteins with a minimum of only 2 amino-acid 244 
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substitutions (Q96L/T99M), and that a chimeric bat FLUAV expressing NS1 with these 245 
substitutions had improved propagation kinetics in some tissue-culture systems (canine 246 
MDCK and human HAP-1), but a seemingly attenuated phenotype in others (human A549 247 
and bat EidNi/41). Notably, this disparate impact did not correlate with host-species, as two 248 
different human cell-lines were identified in which the outcome of infection was opposite. 249 
Therefore, cell-type (and thus unknown differential gene/protein expression profiles or 250 
polymorphisms) likely determine the phenotypic result. Interestingly, the propagation 251 
phenotype in human HAP-1 cells of the chimeric bat FLUAV expressing NS1-Q96L/T99M 252 
was not diminished in an isogenic cell-line completely lacking p85β expression, suggesting 253 
that the amino-acid substitutions used to permit p85β-binding by NS1 also modify an 254 
additional property of this multifunctional viral protein that has yet to be identified. This will 255 
certainly be an interesting area to explore in the future, and may impact our understanding of 256 
other classical influenza A viruses and the biological consequences of certain NS1 257 
polymorphisms that they harbor. Such observations will also have implications when 258 
assessing potential virological consequences of the p85β-binding property arising naturally in 259 
bat FLUAVs. 260 
 261 
Engineering p85β-binding into the bat FLUAV NS1 protein did not result in detectable 262 
activation of PI3K signaling, indicating that additional regions of NS1 are essential for this 263 
function. Indeed, while p85β-binding is necessary for NS1-mediated PI3K activation (38), our 264 
data suggest that it is not sufficient, an observation consistent with previous work (41, 48). 265 
Glutamic acid residues at human FLUAV NS1 positions 96 and 97 (equivalent to bat FLUAV 266 
NS1 positions 97 and 98) do not interact directly with p85β, but have been proposed to form 267 
part of an ‘activating interface’ with the p110 catalytic subunit of the p85β-containing PI3K 268 
heterodimer (41). Although these are the only non-p85β-interface residues so far implicated in 269 
NS1-activated PI3K signaling, they are conserved in the bat FLUAV NS1 proteins, meaning 270 
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that another unidentified region of classical FLUAV NS1 proteins must be responsible for 271 
ensuring PI3K activation. Experiments to uncover this specific region are currently underway, 272 
but it is therefore apparent that more than the 2-4 amino-acid substitutions required for p85β-273 
binding would be necessary to allow bat FLUAV NS1 proteins to fully acquire PI3K 274 
activation potential, constituting a relatively high genetic barrier to natural evolution of this 275 
property. 276 
 277 
Our studies suggest that interactions between NS1 and p85β are not species-specific: bat 278 
FLUAV NS1 proteins do not bind bat p85β. Thus, an open question is why bat FLUAVs have 279 
not retained (or evolved) this property like classical mammalian and avian FLUAVs? One 280 
hypothesis for this observation is that the natural host environment encountered in vivo by bat 281 
FLUAVs is in a particular metabolic state such that viral augmentation of PI3K signaling 282 
would not alter host physiology. Indeed, recent genome sequencing and analysis studies have 283 
begun to uncover major differences between bats and other species, and have linked 284 
specialized adaptations of bats (e.g. flying ability, longevity, hibernation and echolocation) 285 
with specific adaptive evolution of energy metabolism genes. Such genes include those 286 
involved in oxidative phosphorylation (49), insulin/growth factor receptor signaling (50), and 287 
DNA damage repair and apoptosis (51), pathways otherwise known to be regulated by PI3K 288 
in many mammalian systems (52, 53). Possible links between positive selection in bat 289 
metabolic genes and decreased sensitivity to PI3K-mediated regulation need to be validated 290 
experimentally, but could account for bat FLUAV NS1 proteins adopting a different 291 
evolutionary path to those from their classical FLUAV counterparts in other species. Such 292 
functional divergence of bat FLUAV NS1 proteins underscores the uniqueness of these 293 
newly-discovered viruses, and suggests new and intriguing virus-host interaction biology in 294 
bat species that remains to be explored.  295 
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MATERIALS AND METHODS 296 
 297 
Cells. MDCK (canine), 293T (human), A549 (human), 1321N1 (human), EidNi/41 (bat; 298 
Eidolon helvum) (54) and CarperAEC.B-3 (bat; Carollia perspicillata) (55) cells were 299 
cultured in DMEM supplemented with 10% fetal bovine serum (FBS), 100 units/mL 300 
penicillin and 100 µg/mL streptomycin (Gibco Life Technologies). HAP-1 cells (Horizon 301 
Discovery, Austria) were cultured in IMDM supplemented with the same additives as well as 302 
200µM GlutaMax
TM 
(Gibco Life Technologies). The HAP-1 cell-line engineered by 303 
CRISPR/Cas9 to have a 2bp deletion in the PIK3R2 gene (encoding p85β) was purchased 304 
from Horizon Discovery, Austria (catalogue ID: HZGHC003292c006). All cells were 305 
maintained at 37˚C with 5% CO2. 306 
 307 
Expression plasmids. The NS1 cDNA sequences from A/Swine/Texas/4199-2/98 (Sw/Tx/98, 308 
H3N2), A/Nigeria/OG10/2007 (Nig/07, H5N1), A/Shanghai/2/S1078/2013 (Sh/13, H7N9), 309 
A/little yellow shouldered bat/Guatemala/153/2009 (Guat/09, HL17NL10) and A/flat-faced 310 
bat/Peru/033/2010 (Peru/10, HL18NL11) were PCR amplified from existing plasmids and 311 
ligated in-frame with an N-terminal V5-tag into modified pLVX-IRES-ZsGreen1 or pLVX-312 
IRES-Puro plasmids (Clontech, USA). Similar plasmids expressing glutathione S-transferase 313 
(GST) and NS1 sequences from A/Puerto Rico/8/1934 (PR8, H1N1) or A/California/04/09 314 
(Cal09, pdmH1N1) have been described previously (47). All NS1-encoding cDNAs contained 315 
silent mutations in the splice acceptor site to prevent expression of NEP. Human p85α and 316 
p85β cDNA sequences from existing plasmids, or the bat (Myotis lucifugus) p85β cDNA 317 
sequence generated using the GeneArt gene synthesis service (Thermo Fisher), were PCR 318 
amplified and ligated in-frame into p3xFLAG-CMV-7.1 (Sigma-Aldrich) so as to express 319 
with N-terminal FLAG tags. Two step overlap PCR or Quikchange II XL (Agilent 320 
Technologies, Switzerland) was used to introduce site-directed mutations into cDNAs as 321 
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required. The identity of all constructs was confirmed by sequencing. All plasmid 322 
transfections were performed using Fugene HD (Promega) at 1:3 DNA:transfection reagent 323 
ratio. As appropriate, generation of lentiviruses and production of stable cell-lines 324 
constitutively expressing proteins of interest were carried out as previously described (38). 325 
 326 
Virus reverse genetics. Plasmids for rescuing chimeric, recombinant HL17NL10 virus 327 
(variant C3: PA-S550R and M2-N31S/T70A) were described previously (14). pHW2000 328 
rescue plasmids comprising the genome ends and packaging sequences of HL17NL10 and the 329 
PR8 HA or NA glycoprotein ORFs were generated as described (15). Briefly, the untranslated 330 
regions of PR8 HA and NA genome segments were replaced with the genome ends and 331 
packaging sequences of the corresponding segments of HL17NL10 by assembly PCR. 332 
Plasmids encoding NS segments where NS1 and NEP ORFs were separated by the 2A self-333 
cleaving peptide of porcine teschovirus (allowing N-terminal V5-tagging of NS1) were 334 
generated by assembly PCR according to a previous strategy (56). All generated NS chimeras 335 
contained silent mutations in the splice acceptor and donor sites of the ORFs to prevent 336 
aberrant splicing, and duplicated genome packaging sequences were introduced flanking the 337 
NS1 ORF to avoid packaging defects. Quikchange II XL (Agilent Technologies, Switzerland) 338 
was used to introduce site-directed mutations into cDNAs as required. For rescues, 6x10
5
 339 
293T cells were seeded in 6-well plates and co-transfected 24h later with the 8 pDZ- or 340 
pHW2000- based plasmids. Twenty-four hours post-transfection, cells were washed once in 341 
sterile phosphate-buffered saline (PBS) and 3x10
5
 MDCK cells were added in DMEM 342 
supplemented with 1µg/mL tosylsulfonyl phenylalanyl chloromethyl ketone (TPCK)-treated 343 
trypsin (Sigma-Aldrich, MO). Forty-eight hours later, supernatants were harvested, viruses 344 
plaque-purified, and virus stocks grown and titrated using standard methods in MDCK cells. 345 
RNA was extracted from stock aliquots using the ReliaPrep
TM
 RNA Cell Miniprep System 346 
 o
n
 January 19, 2018 by Universitaet Zuerich
http://jvi.asm.org/
D
ow
nloaded from
 
15 
 
(Promega), and the NS genomic segments of each virus were fully sequenced after segment-347 
specific reverse transcription-PCR (RT-PCR) to ensure absence of undesired mutations. 348 
 349 
Virus infections. For all infections, viruses were diluted in PBS supplemented with 100 350 
units/mL penicillin, 100 µg/mL streptomycin (Gibco Life Technologies), 0.3% BSA (Sigma-351 
Aldrich) and 1 mM Ca
2+
/Mg
2+
. For HAP-1 cells, cells were seeded onto poly-L-lysine 352 
(Sigma-Aldrich) coated plates and infected 24 h later at the indicated multiplicity of infection 353 
(MOI) for 1 h at 37°C. Following infection, cells were washed three times and overlaid with 354 
FBS-free IMDM. For serum-starvation experiments, cells were washed 3 times with FBS-free 355 
IMDM and incubated overnight prior to infection. 356 
 357 
For virus growth analyses, cells in 12-well plates were infected with the indicated virus at the 358 
indicated MOI. Following infection at 37°C for 1 h, cells were washed three times with PBS, 359 
and overlaid with DMEM supplemented with 100 units/mL penicillin, 100 µg/mL 360 
streptomycin (Gibco Life Technologies) and 0.5 μg/mL TPCK-treated trypsin (Sigma-361 
Aldrich). Supernatant samples were harvested at the indicated timepoints and stored at -80°C 362 
prior to titration by standard plaque assay. 363 
 364 
Sequencing of p85β (PIK3R2) iSH2 domains from bat species. Bats (S. lilium) were 365 
captured with mist nets. Specimens were collected and processed after approval of the 366 
Institutional Committee of Care and Use of Animals (IACUC) of the University of Costa Rica 367 
(CICUA-36-13) according to national guidelines for animal caring described in the Costa 368 
Rica National Law for Animal Welfare 7451. For sequencing, 2.5x10
5
 CarperAEC.B-3 cells 369 
seeded in 12-well plates, or an equivalent amount of cellular material from S. lilium, were 370 
lysed, and RNA extracted, using the ReliaPrep
TM
 RNA Cell Miniprep System (Promega). RT-371 
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PCR products were generated, and directly sequenced, using specific primers annealing to 372 
conserved regions of PIK3R2 flanking the sequence encoding the p85β iSH2 domain. 373 
 374 
Immunoprecipitations. Transfected (2 μg total DNA, 48 h in 293T) or infected (MOI 5 375 
PFU/cell, 8 h in HAP-1) cells in 25cm
2
 flasks or 6-well plates were lysed on ice in 1mL of 376 
20mM Tris-HCl (pH 7.8), 5mM EDTA, 0.5% (v/v) NP40, and 650mM NaCl, supplemented 377 
with a cOmplete
TM
 mini protease inhibitor tablet (Roche, Switzerland). Lysates were clarified 378 
using a 29G (0.33mm) needle and centrifugation at 13,000 rpm for 40 mins at 4°C. Soluble 379 
fractions were then incubated with 1 μg of anti-V5 antibody (Bio-Rad) for 2 hours at 4°C 380 
prior to further incubation overnight at 4°C with 12.5 μL protein G sepharose beads (Sigma-381 
Aldrich).  Following extensive washing, remaining proteins were dissociated from the beads 382 
using urea disruption buffer (6M urea, 1M β-mercaptoethanol, 4% SDS) and heating at 95°C 383 
for 10 min. Samples were stored at -20˚C until analysis by SDS-PAGE and western blotting. 384 
 385 
Akt phosphorylation assays. 1321N1 cells stably expressing the indicated V5-tagged protein 386 
were seeded into 12-well plates and serum-starved the following day for 1 h.  Cell lysates 387 
were harvested in urea disruption buffer and stored at -20˚C until analysis by SDS-PAGE and 388 
western blotting.  389 
 390 
SDS-PAGE and western blotting. Samples were sonicated to shear nucleic acids and then 391 
boiled for 5 min. Polypeptides were resolved by SDS-PAGE on NuPAGE 4-12% Bis-Tris 392 
protein gels (ThermoFisher), followed by transfer to nitrocellulose membranes (GE 393 
Healthcare Life Sciences). Proteins were detected by western blotting using the following 394 
primary antibodies: mouse anti-V5 (Bio-Rad, MCA1360); mouse anti-FLAG (Sigma-Aldrich, 395 
#F3165); mouse anti-p85β (T15; AbD Serotech, MCA1170G); rabbit anti-actin (Sigma-396 
Aldrich, #A2103); rabbit anti-Akt (Cell Signaling Technology, #4691); rabbit anti-pAkt 397 
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(S473) (Cell Signaling Technology, #4060); rabbit anti-NS1 (1-73) (57) (kindly provided by 398 
Adolfo García-Sastre, Icahn School of Medicine at Mount Sinai, New York, USA); and rabbit 399 
anti-NP (kindly provided by Silke Stertz, University of Zurich, Switzerland). Secondary 400 
antibodies were fluorochrome-conjugated: anti-mouse (ThermoFisher Scientific, #SA5-401 
10176) and anti-rabbit (ThermoFisher Scientific, #SA5-10036). A LI-COR Odyssey Fc 402 
scanner was used for detection.  403 
 404 
Structural analyses. Structural representations were visualized using the appropriate PDB 405 
file and PyMOL (58). 406 
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FIGURE LEGENDS 422 
 423 
Figure 1. Strain-specific interaction of FLUAV NS1 proteins with human p85β.  293T 424 
cells were co-transfected for 48 h with plasmids expressing the indicated V5-tagged NS1 425 
protein (or GST) and FLAG-tagged human p85α or p85β. Following cell lysis, clarification 426 
and anti-V5 immunoprecipitation, soluble (input) and pull-down (IP:α-V5) fractions were 427 
analyzed by SDS-PAGE and western blot. (A) Interaction studies of human (PR8, Cal/09), 428 
swine (Sw/Tx/98) and avian (Nig/07, Sh/13) FLUAV NS1 proteins. (B) Interaction studies of 429 
bat (Guat/09, Peru/10) FLUAV NS1 proteins. Data are representative of 3 independent 430 
experiments. 431 
 432 
Figure 2. Bat FLUAV NS1 proteins do not show a species-specific interaction with p85β.  433 
(A) 293T cells were co-transfected for 48 h with plasmids expressing the indicated V5-tagged 434 
NS1 protein (or GST) and FLAG-tagged human (Homo sapiens, H.s.) or bat (Myotis 435 
lucifugus, M.l.) p85β. Following cell lysis, clarification and anti-V5 immunoprecipitation, 436 
soluble (input) and pull-down (IP:α-V5) fractions were analyzed by SDS-PAGE and western 437 
blot. (B) Sequence alignment of iSH2 domains from human and bat p85β. Human (H. 438 
sapiens), little yellow shouldered bat (S. lilium), little brown bat (M. lucifugus) and Seba’s 439 
short-tailed bat (C. perspicillata) p85β iSH2 domain amino acid sequences (residues 496-614) 440 
were aligned. Human/bat differences are highlighted with boxes, shading indicates residues 441 
differing between bat species. (C) Experiment performed as in (A), except using the indicated 442 
bat p85β mutants. For (A) and (C), data are representative of 3 independent experiments. 443 
 444 
Figure 3. Bat FLUAV is an inefficient activator of PI3K signaling during infection. (A) 445 
Serum-starved 1321N1 cells stably expressing the indicated V5-tagged proteins were lysed, 446 
and levels of the indicated proteins were analyzed by SDS-PAGE and western blot. (B) 447 
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Schematic representation of mRNAs generated by wild-type (upper) or engineered (lower) 448 
NS segments. SD, splice donor; SA, splice acceptor; 2A, 2A sequence from porcine 449 
teschovirus. (C) HAP-1 cells were infected for 8 h with chHL17 viruses expressing the 450 
indicated V5-tagged NS1 proteins at a MOI of 5 PFU/cell. Following cell lysis, clarification 451 
and anti-V5 immunoprecipitation, soluble (input) and pull-down (IP:α-V5) fractions were 452 
analyzed by SDS-PAGE and western blot. (D) Serum-starved HAP-1 cells were infected with 453 
chHL17 viruses expressing the indicated V5-tagged NS1 proteins at a MOI of 5 PFU/cell. 454 
Cells were lysed at 3, 6 and 9 hours post-infection and levels of the indicated proteins were 455 
analyzed by SDS-PAGE and western blot. For (A), (C) and (D), data are representative of at 456 
least 2 independent experiments. 457 
 458 
Figure 4. Engineering the bat FLUAV (Guat/09) NS1 protein to bind p85β. (A) Crystal 459 
structure of the PR8/NS1 ED in complex with part of the p85β iSH2 domain. The NS1 ED is 460 
shown in gray, with p85β contact residues highlighted in yellow. The p85β iSH2 domain is 461 
colored blue. The six NS1 amino acid residues chosen for mutagenesis studies (see B, 462 
Guat/09 numbering) are highlighted in red. Figure generated using PyMOL with PDB ID: 463 
3L4Q. (B) Comparison of key NS1 ED residues between human (PR8, Cal09), swine 464 
(Sw/Tx/98), avian (Nig/07, Sh/13) and bat (Guat/09, Peru/10) NS1 proteins. #Guat/09 465 
numbering. (C-D) 293T cells were co-transfected for 48 h with plasmids expressing the 466 
indicated V5-tagged NS1 protein (or GST) and FLAG-tagged human p85β. Following cell 467 
lysis, clarification and anti-V5 immunoprecipitation, soluble (input) and pull-down (IP:α-V5) 468 
fractions were analyzed by SDS-PAGE and western blot. Data are representative of at least 2 469 
independent experiments. 470 
 471 
Figure 5. Engineering the bat FLUAV (Peru/10) NS1 protein to bind p85β. (A-B) 293T 472 
cells were co-transfected for 48 h with plasmids expressing the indicated V5-tagged NS1 473 
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protein (or GST) and FLAG-tagged human p85β. Following cell lysis, clarification and anti-474 
V5 immunoprecipitation, soluble (input) and pull-down (IP:α-V5) fractions were analyzed by 475 
SDS-PAGE and western blot. (C) Experiment performed as in (A), except using the indicated 476 
bat p85β mutants. Guat/09 3x = Q96L/T99M/R145T; Peru/10 4x = 477 
V96L/T99M/N100I/R145T. For all panels, data are representative of at least 2 independent 478 
experiments. 479 
 480 
Figure 6. Characterization of a chimeric bat FLUAV expressing an engineered p85β-481 
binding NS1 protein. (A) Plaque phenotype and (B) multicycle growth analysis of chHL17-482 
WT and chHL17-2x viruses in MDCK cells. (C-E) Multicycle growth analysis of chHL17-483 
WT and chHL17-2x viruses in HAP-1 (C), A549 (D) and EidNi/41 (E) cells. For all growth 484 
curves, data represent mean values from 3 independent experiments (± SD).  Significance was 485 
calculated using the Student’s t-test comparing cHL17-WT and chHL17-2x virus titers at each 486 
time point (** p<0.01, * p<0.05). 487 
 488 
Figure 7. Role of p85β and PI3K activation in the phenotype of a chimeric bat FLUAV 489 
expressing NS1-Q96L/T99M. (A) Serum-starved 1321N1 cells stably expressing the 490 
indicated V5-tagged proteins were lysed, and levels of the indicated proteins were analyzed 491 
by SDS-PAGE and western blot. (B) Western blot analysis of wild-type or PIK3R2 (p85β) 492 
knock-out HAP-1 cells. For (A) and (B), data are representative of at least 2 independent 493 
experiments. (C) Multicycle growth analysis of chHL17-WT and chHL17-2x viruses in 494 
PIK3R2 (p85β) knock-out HAP-1 cells. Data represent mean values from 3 independent 495 
experiments (± SD). (D) Ratios of chHL17-2x to chHL17-WT propagation titers (represented 496 
as area under the curve (AUC) values) in wild-type and PIK3R2 (p85β) knock-out HAP-1 497 
cells (original data from Figs. 6C and 7C). For (C) and (D), significance was calculated using 498 
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the Student’s t-test comparing chHL17-WT and chHL17-2x virus titers at each time point (* 499 
p<0.05), or AUC ratios in each cell-line (ns, non significant).   500 
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